FiercePharmaOriginal article
{"a":[{"_":"Cellares downsizes New Jersey operations after losing BMS cell therapy contract","$":{"href":"/pharma/cellares-restructuring-rolls-new-jersey-amid-cell-therapy-client-loss","hreflang":"en"}}]}
Negative
AI Analysis
Summary
Cellares is downsizing its New Jersey operations after losing Bristol Myers Squibb as a client, as part of a right-sizing initiative announced by its CEO.
Importance:3/10
Sentiment:
-0.70
restructuringcontract_losscell_therapyoperations
Related Companies
Read the original article
Published by FiercePharma on September 2, 2026 9:12 AM
